Sphera Funds Management’s Allena Pharmaceuticals ALNA Stock Holding History

Sphera Funds Management’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-667,800	Closed	-$643K	–	115
2020 Q1	$643K	Sell	667,800 -250,000	-27%	-$500K	0.08%	67
2019 Q4	$2.51M	Buy	917,800 +243,919	+36%	+$801K	0.21%	71
2019 Q3	$2.65M	Buy	673,881 +182,688	+37%	+$784K	0.41%	61
2019 Q2	$2M	Buy	491,193 +60,000	+14%	+$328K	0.27%	72
2019 Q1	$3.03M	Buy	431,193 +85,994	+25%	+$623K	0.28%	76
2018 Q4	$1.88M	Buy	345,199 +50,000	+17%	+$431K	0.21%	77
2018 Q3	$3.17M	Buy	295,199 +27,850	+10%	+$306K	0.36%	76
2018 Q2	$3.48M	Sell	267,349 -142,850	-35%	-$2.06M	0.48%	67
2018 Q1	$4.52M	Buy	410,199 +85,199	+26%	+$712K	0.69%	47
2017 Q4	$3.27M	Buy	+325,000	New	+$4.01M	0.38%	64

Other funds holding ALNA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Sphera Funds Management's ALNA Position: Q2 2020 in Review

Sphera Funds Management sold out of Allena Pharmaceuticals (ALNA) in Q2 2020, closing a stake of 667,800 shares — an estimated $643K sold.

Sphera Funds Management first reported a position in ALNA in Q4 2017 and held it in 10 quarters. The position peaked at $4.52M in Q1 2018. 30 funds tracked by Wall St. Rank hold ALNA as of Q2 2020.

Sphera Funds Management reported no remaining Allena Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Sphera Funds Management sold 667,800 Allena Pharmaceuticals shares in Q2 2020, an estimated $643K.
Sphera Funds Management first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 10 quarters.
Sphera Funds Management's Allena Pharmaceuticals position peaked at $4.52M in Q1 2018.
30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2020.

Based on Sphera Funds Management's 13F filing for Q2 2020, filed 13 Aug 2020.